| Date | Title | Description |
| 29.03.2026 | Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple | - |
| 03.06.2024 | Landmark review spotlights challenge of judging psychedelic therapies | figcaption>span]:font-sans">
The challenges of mainstreaming psychedelic therapies for conditions like PTSD, anxiety and major depression will be brought home this week when federal drug advisers scrutinize what could be the firs... |
| 19.08.2022 | Mind Medicine surges 78% after report reveals activist stake of college student who made $110 million in Bed Bath & Beyond rally | Mind Medicine stock jumped as high as 78% on Thursday after a report revealed a college student activist stake.
The investor, Jake Freeman, and his uncle own a 4.5% stake in the Mind Med, according to the FT.
Advertisement
A small pharmaceu... |
| 08.01.2022 | Stephen Hurst Resigns from MindMed Board of Directors | NEW YORK, Jan. 7, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-derived therapies, announces the resignation of Stephen H... |
| 29.12.2021 | MindMed Announces Transitions to Management Team | - Bradford Cross, Chief Technology Officer to transition; Don Gehlert, PhD, Chief Scientific Officer to transition to Senior Scientific Advisor -
NEW YORK, Dec. 29, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MME... |
| 29.12.2021 | MindMed Announces Transitions to Management Team | - Bradford Cross, Chief Technology Officer to transition; Don Gehlert, PhD, Chief Scientific Officer to transition to Senior Scientific Advisor -
NEW YORK, Dec. 29, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MME... |
| 29.12.2021 | MindMed Announces Transitions to Management Team | - Bradford Cross, Chief Technology Officer to transition; Don Gehlert, PhD, Chief Scientific Officer to transition to Senior Scientific Advisor -
NEW YORK, Dec. 29, 2021 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE... |
| 21.12.2021 | FDA slams clinical hold on tiny psychedelics player's shot at bringing LSD-assisted therapy to more patients | Psychedelic therapy has emerged once again as a potentially promising path to treating neurological conditions, but one tiny biotech is now facing a holdup at the FDA in bringing its LSD program to more patients.
The FDA... |
| 14.12.2021 | MindMed Appoints Robert Barrow as Chief Executive Officer and Director | -Mr. Barrow previously served as interim Chief Executive Officer and Chief Development Officer of MindMed
-Carol Vallone appointed as Chair of the Board of Directors, Andreas Krebs appointed as Vice Chair and Perry Dellelce transitions from... |
| 03.11.2021 | Psychedelics Offer Hope for Mental Disorders, Addiction | NetworkNewsWire Editorial Coverage
NEW YORK, Nov. 3, 2021 /PRNewswire/ -- Global destigmatization, changing regulations and an upswing in research are speaking loudly to the opportunity for psychedelics to provide tangible improvements in m... |
| 03.11.2021 | Psychedelics Offer Hope for Mental Disorders, Addiction | NEW YORK, Nov. 3, 2021 /PRNewswire/ -- Global destigmatization, changing regulations and an upswing in research are speaking loudly to the opportunity for psychedelics to provide tangible improvements in medicine to address some of the most... |
| 13.08.2021 | Mind Medicine MindMed : MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline | NEW YORK, Aug. 12, 2021 /CNW/ -- MindMed (Nasdaq: MNMD), (NEO: MMED), (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its quarterly financial results for the quarter ended June 30, 2021.
Q2 2021... |
| 12.08.2021 | MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline | NEW YORK, Aug. 12, 2021 /CNW/ -- MindMed (Nasdaq: MNMD), (NEO: MMED), (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its quarterly financial results for the quarter ended June 30, 2021.
Q2 2021... |
| 12.08.2021 | MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline | |
| 12.08.2021 | MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline | NEW YORK, Aug. 12, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD), (NEO: MMED), (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its quarterly financial results for the quarter ended June 30, 2021.
... |
| 08.07.2021 | MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company | |
| 04.06.2021 | Deepak Chopra did LSD for the first time in a Harvard lab and felt his consciousness shift while staring at a photo of Mother Teresa | Mental health advocate Deepak Chopra wants the world to learn about the healing power of psychedelic drugs.
Chopra told Insider he had his first psychedelic trip in 1965 while in medical school. It was part of an experiment.
Recent research... |
| 27.05.2021 | MindMed announces shareholder Meeting Results | |
| 24.05.2021 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Announces Launch of Collaboration with Nextage Therapeutics' Brain Targeting Liposome System | MindMed (NASDAQ: MNMD, NEO: MMED, DE: MMQ), a leading clinical stage psychedelic medicine company, and Nextage Therapeutics (TASE: NXTG), an Israeli innovative drug development company, announce the execution of a Memorandum of Understandin... |
| 20.05.2021 | MindMed Announces the Approval of Mescaline Study | |
| 17.05.2021 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : First Quarter 2021 Management's Discussion and Analysis | MIND MEDICINE (MINDMED) INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS
FOR THE QUARTER ENDED MARCH 31, 2021
Dated: May 13, 2021
http://mindmed.co
MIND MEDICINE (MINDMED) INC.
Management's Discussion and Analysis
ABOUT THIS MANAGEMENT'S DISCUSSIO... |
| 14.05.2021 | MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director | |
| 14.05.2021 | MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline | |
| 14.05.2021 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline | NEW YORK, May 14, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed'' or the "Company") (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, has announced its quarterly financial res... |
| 07.05.2021 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics | Mind Medicine (MindMed) Inc. ('MindMed' or the 'Company') (NASDAQ: MNMD) (NEO: MMED), (DE: MMQ), a leading psychedelic-inspired medicine company announces the launch of its Project Angie to advance the development of psychedelics, including... |
| 05.05.2021 | MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics | |
| 30.04.2021 | Weed on Capitol Hill | Welcome to another edition of Insider Cannabis. Reuters
Welcome to Insider Cannabis, our weekly newsletter where we’re bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom.... |
| 05.04.2021 | MindMed Announces the Publication of New Data on Personalized MDMA Dosing | |
| 30.03.2021 | MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform | Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ($30.5 million CAD) for year ended December 31, 2020
NEW YORK, March 30, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Compan... |
| 30.03.2021 | MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform | Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ($30.5 million CAD) for year ended December 31, 2020
NEW YORK, March 30, 2021 /CNW/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company"... |
| 30.03.2021 | MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform | Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ($30.5 million CAD) for year ended December 31, 2020
NEW YORK, March 30, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Compan... |
| 30.03.2021 | MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS | |
| 29.03.2021 | MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board | |
| 22.03.2021 | MindMed Announces Inclusion in FTSE Russell Indexes | |
| 09.03.2021 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m) | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, March 9, 2021 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF, DE: MMQ) ("MindMed" or the "Company"... |
| 27.02.2021 | MindMed Completes Acquisition of HealthMode | Mind Medicine Inc. (NEO: MMED,OTCQB: MMEDF, DE: MMQ), a NYC-based psychedelic medicine biotech company, closed the previously announced acquisition of HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence... |
| 26.02.2021 | MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company | |
| 18.02.2021 | MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company | |
| 11.02.2021 | MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds | |
| 20.01.2021 | MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD | |
| 12.01.2021 | MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers | |
| 07.01.2021 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand | Bolsters Cash on Hand to CAD $183.0m (USD $144.4m)
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Jan. 7, 2021 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED), (OTCQB: MMEDF), (D... |
| 07.01.2021 | Mind Medicine MindMed : MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand | Bolsters Cash on Hand to CAD $183.0m (USD $144.4m)
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Jan. 7, 2021 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED), (OTCQB: MMEDF), (D... |
| 14.12.2020 | MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy | |
| 11.12.2020 | Mind Medicine MindMed : MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m) | Post-Financing Cash Reserves of CAD $85m (USD $66.4m) to Enable Advancement of Digital Therapeutics Division and Growing Clinical Trial Pipeline
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STAT... |
| 11.12.2020 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m) | Post-Financing Cash Reserves of CAD $85m (USD $66.4m) to Enable Advancement of Digital Therapeutics Division and Growing Clinical Trial Pipeline
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STAT... |
| 09.12.2020 | Mind Medicine MindMed : MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing | Financing To Support The Development Of MindMed's Digital Medicine Division And Psychedelic Inspired Medicines And Experiential Therapies
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORO... |
| 09.12.2020 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing | Financing To Support The Development Of MindMed's Digital Medicine Division And Psychedelic Inspired Medicines And Experiential Therapies
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORO... |
| 01.12.2020 | Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Nov. 30, 2020 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED), (OTCQB: MMEDF) ("MindMed" or the "Company") is p... |
| 01.12.2020 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Nov. 30, 2020 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED), (OTCQB: MMEDF) ("MindMed" or the "Company") is p... |
| 16.11.2020 | MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities | |
| 02.11.2020 | MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD | |
| 27.10.2020 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing | FINANCING TO SUPPORT THE DEVELOPMENT OF MINDMED'S GROWING PIPELINE OF PSYCHEDELIC INSPIRED MEDICINES AND EXPERIENTIAL THERAPIES
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Oct. ... |
| 17.10.2020 | MIND MEDICINE (MINDMED) INC.
Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Oct. 16, 2020 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) ("MindMed" or the "Company") is pl... |
| 25.08.2020 | MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD | |
| 17.12.2019 | Addiction Treatment Gets Psychedelic With ‘Shark Tank’ Investor-Approved Startup | Hallucinogenic drugs are now seen as a potential cure for depression, alcoholism and a means to get people off opioids. Photo Media/ClassicStock/Getty Images
We all know the lore of LSD microdosing in Silicon Valley. It’s been hailed as a j... |
| - | Как развивается рынок стартапов для психического здоровья | В последние несколько лет самые предприимчивые инвесторы начали заходить в сферу психического здоровья. И этому немало способствовала эпидемия COVID-19.
4
16 просмотров
По оценкам, до пандемии в США около половины взрослых и детей с психиче... |
| - | Wealthy donors are fueling a psychedelics renaissance as universities vie for funding to study 'magic mushrooms' and MDMA | This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Universities are establishing psychedelics centers to study compounds like psilocybin and MDMA. Cash from wealthy donors and promising earl... |
| - | Mental Care: самый быстрорастущий рынок цифрового здоровья | В последние несколько лет самые предприимчивые инвесторы начали заходить в сферу психического здоровья. И этому немало способствовала эпидемия COVID-19.
5
999 просмотров
По оценкам, до пандемии в США около половины взрослых и детей с психич... |
| - | Top psychedelics VCs predict a tech boom and a rise of clinics over the next year | A woman demonstrates the patient experience at Field Trip, a psychedelic-therapy clinic in Toronto. COLE BURSTON/AFP via Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redee... |
| - | Mind Medicine MindMed : MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m) | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, March 9, 2021 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF, DE: MMQ) ("MindMed" or the "Company"... |
